Vasopressin to Attenuate Pulmonary Hypertension and Improve Systemic Blood Pressure After Correction of Obstructed Total Anomalous Pulmonary Venous Return
Overview
Affiliations
Use of vasopressin in persistent pulmonary hypertension of the newborn: A case series.
Joshi S, Quinones Cardona V, Menkiti O SAGE Open Med Case Rep. 2022; 10:2050313X221102289.
PMID: 35693924 PMC: 9178974. DOI: 10.1177/2050313X221102289.
Pulmonary Hypertension in Intensive Care Units: An Updated Review.
Nowroozpoor A, Malekmohammad M, Seyyedi S, Hashemian S Tanaffos. 2020; 18(3):180-207.
PMID: 32411259 PMC: 7210574.
Sugawara Y, Mizuno Y, Oku S, Goto T Br J Anaesth. 2019; 122(4):437-447.
PMID: 30857600 PMC: 6435915. DOI: 10.1016/j.bja.2019.01.014.
Hoeper M, Benza R, Corris P, de Perrot M, Fadel E, Keogh A Eur Respir J. 2018; 53(1).
PMID: 30545979 PMC: 6351385. DOI: 10.1183/13993003.01906-2018.
Arginine Vasopressin and Copeptin in Perinatology.
Evers K, Wellmann S Front Pediatr. 2016; 4:75.
PMID: 27532032 PMC: 4969663. DOI: 10.3389/fped.2016.00075.